Advanced Enzyme Tech Stock Screener | Share Price & Fundamental Analysis
ADVENZYMES
Biotechnology
Screen Advanced Enzyme Tech share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹303.30
▲
1.15 (0.38%)
Share Price BSE
₹303.25
▲
1.10 (0.36%)
Market Cap
₹3,430.84 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.30
EPS (TTM)
₹11.72
Dividend Yield
1.70%
Debt to Equity
0.03
52W High
₹360.35
52W Low
₹259.85
Operating Margin
27.00%
Profit Margin
15.34%
Revenue (TTM)
₹176.00
EBITDA
₹54.00
Net Income
₹27.00
Total Assets
₹1,621.00
Total Equity
₹1,469.00
Advanced Enzyme Tech Share Price History - Stock Screener Chart
Screen ADVENZYMES historical share price movements with interactive charts. Analyze price trends and patterns.
Advanced Enzyme Tech Company Profile - Fundamental Screener
Screen Advanced Enzyme Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ADVENZYMES shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE837H01020
Advanced Enzyme Tech Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ADVENZYMES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,621 | 1,536 | 1,422 | 1,268 | 1,156 | 979 | 811 | 732 | 589 | 451 |
| Current Assets | 880 | 810 | 722 | 604 | 516 | 376 | 282 | 211 | 138 | 140 |
| Fixed Assets | 679 | 650 | 649 | 619 | 604 | 563 | 496 | 491 | 421 | 286 |
| Liabilities | ||||||||||
| Total Liabilities | 1,621 | 1,536 | 1,422 | 1,268 | 1,156 | 979 | 811 | 732 | 589 | 451 |
| Current Liabilities | 56 | 58 | 60 | 67 | 56 | 52 | 41 | 51 | 42 | 56 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,469 | 1,371 | 1,284 | 1,140 | 1,033 | 867 | 705 | 582 | 485 | 283 |
| Share Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves & Surplus | 1,399 | 1,302 | 1,213 | 1,066 | 949 | 817 | 657 | 537 | 442 | 256 |
Screen ADVENZYMES income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 176 | 195 | 195 | 167 | 162 | 156 | 177 | 150 | 154 | 164 | 175 | 135 | 123 | 143 | 151 |
| Expenses | 122 | 130 | 125 | 118 | 103 | 104 | 114 | 99 | 103 | 107 | 107 | 91 | 90 | 99 | 100 |
| EBITDA | 54 | 65 | 70 | 50 | 58 | 52 | 63 | 51 | 51 | 57 | 68 | 44 | 33 | 44 | 50 |
| Operating Profit % | 27.00% | 30.00% | 33.00% | 26.00% | 33.00% | 29.00% | 33.00% | 29.00% | 30.00% | 33.00% | 33.00% | 31.00% | 26.00% | 29.00% | 29.00% |
| Depreciation | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 44 | 55 | 60 | 40 | 49 | 42 | 53 | 42 | 41 | 48 | 59 | 34 | 24 | 34 | 41 |
| Tax | 17 | 15 | 15 | 10 | 14 | 9 | 14 | 10 | 12 | 13 | 16 | 9 | 6 | 8 | 13 |
| Net Profit | 27 | 40 | 45 | 30 | 35 | 33 | 39 | 32 | 29 | 35 | 43 | 25 | 18 | 26 | 28 |
| EPS | 2.37 | 3.57 | 3.87 | 2.53 | 3.05 | 2.94 | 3.36 | 2.87 | 2.58 | 3.08 | 3.74 | 2.19 | 1.60 | 2.34 | 2.63 |
Advanced Enzyme Tech Cash Flow Screener - Liquidity Fundamentals
Screen ADVENZYMES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 143 | 141 | 140 | 122 | 163 | 141 | 129 | 116 | 107 | 93 |
| Investing Activities | -90 | -65 | -286 | 2 | -27 | -43 | -124 | -60 | -60 | -10 |
| Financing Activities | -73 | -59 | -26 | -49 | -26 | -39 | -43 | -2 | -65 | -63 |
| Net Cash Flow | -20 | 17 | -171 | 75 | 109 | 60 | -38 | 54 | -18 | 21 |
Screen ADVENZYMES shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 43.08% | 43.08% | 43.07% | 43.49% | 43.02% | 42.95% | 42.93% | 49.87% |
| FII Holding | 11.90% | 23.46% | 25.41% | 23.01% | 12.03% | 12.63% | 12.58% | 0.00% |
| DII Holding | 8.19% | 8.45% | 6.41% | 7.56% | 8.08% | 8.02% | 8.18% | 5.73% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.68% | 16.92% | 16.95% | 15.43% | 16.42% | 16.04% | 16.11% | 13.28% |
| Other Holding | 20.16% | 8.10% | 8.15% | 10.51% | 20.45% | 20.36% | 20.21% | 31.11% |
| Shareholder Count | 65,322 | 67,589 | 69,637 | 68,640 | 65,222 | 66,758 | 67,351 | 77,537 |
Advanced Enzyme Tech Dividend Screener - Share Yield Analysis
Screen ADVENZYMES dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹5.20 | 1.69% |
| 2024-March | ₹5.10 | 1.83% |
| 2023-March | ₹1.00 | 0.29% |
| 2022-March | ₹1.00 | 0.42% |
| 2021-March | ₹0.90 | 0.32% |
| 2020-March | ₹0.60 | 0.17% |
| 2019-March | ₹0.60 | 0.42% |
| 2018-March | ₹0.50 | 0.27% |
| 2017-March | ₹0.40 | 0.19% |
| 2016-March | ₹1.00 | 0.24% |
Advanced Enzyme Tech Index Membership - Market Screener Classification
Screen ADVENZYMES by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Advanced Enzyme Tech Market Events Screener - Corporate Actions
Screen ADVENZYMES market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -3.00% |
| 2025-08-02 | 2025-08-02 | Quarterly Result Announcement | NA | 9.08% |
| 2025-07-30 | 2025-07-30 | Annual General Meeting | NA | 17.52% |
| 2025-07-23 | 2025-07-23 | Dividend | ₹ 1.20 /share | 14.50% |
| 2025-05-16 | 2025-05-17 | Dividend | ₹ 4.00 /share | -2.14% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | 3.69% |
| 2025-02-08 | 2025-02-08 | Quarterly Result Announcement | NA | 0.59% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | 8.49% |
| 2024-07-25 | 2024-07-25 | Annual General Meeting | NA | -0.77% |
| 2024-07-18 | 2024-07-18 | Dividend | ₹ 1.10 /share | -4.60% |
| 2024-05-17 | 2024-05-18 | Dividend | ₹ 4.00 /share | -5.22% |
| 2023-08-04 | 2023-08-05 | Dividend | ₹ 1.00 /share | 18.08% |
| 2023-05-19 | 2023-05-20 | Dividend | ₹ 4.00 /share | -4.88% |
| 2022-08-11 | 2022-08-12 | Dividend | ₹ 1.00 /share | -7.09% |
| 2021-08-31 | Dividend | ₹ 0.90 /share | -16.73% |
Advanced Enzyme Tech Competitors Screener - Peer Comparison
Screen ADVENZYMES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 37,510 | 72.81 | 1,930 | 30.15% | 451 | 48.51 |
| Advanced Enzyme Tech | 3,431 | 22.68 | 670 | 1.44% | 134 | 46.00 |
| Genesis IBRC | 116 | -522.22 | 4 | % | 0 | 29.14 |
| Vivo Bio Tech | 71 | 17.52 | 52 | 13.19% | 7 | 58.32 |
| Shree Ganesh Bio-Tech | 25 | 24 | 14.55% | 0 | 42.15 | |
| Genomic Valley Biotech | 7 | 72.03 | 1 | 300.00% | 0 | 42.40 |
Advanced Enzyme Tech Company Announcements - News Screener
Screen ADVENZYMES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Board Meeting Outcome | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-04 | Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30 September 2025 | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-07 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-22 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-09-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-09-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-08-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-08-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-02 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |